TNF blockade enhances the efficacy of myxoma virus-based oncolytic virotherapy

BACKGROUND: Oncolytic virotherapy (OV) represents a method to treat a variety of solid tumors by inducing antitumor immune responses. While this therapy has been extremely efficacious in preclinical models, translating these successes into human patients has proven challenging. One of the major reas...

Descripción completa

Detalles Bibliográficos
Autores principales: Valenzuela-Cardenas, Miriam, Gowan, Cody, Dryja, Parker, Bartee, Mee Y, Bartee, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114862/
https://www.ncbi.nlm.nih.gov/pubmed/35577502
http://dx.doi.org/10.1136/jitc-2022-004770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114862/
https://www.ncbi.nlm.nih.gov/pubmed/35577502
http://dx.doi.org/10.1136/jitc-2022-004770

Ejemplares similares